Page last updated: 2024-10-20

pyruvic acid and HIV-Associated Lipodystrophy Syndrome

pyruvic acid has been researched along with HIV-Associated Lipodystrophy Syndrome in 1 studies

Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.

HIV-Associated Lipodystrophy Syndrome: Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deveaud, C1
Beauvoit, B1
Hagry, S1
Galinier, A1
Carrière, A1
Salin, B1
Schaeffer, J1
Caspar-Bauguil, S1
Fernandez, Y1
Gordien, JB1
Breilh, D1
Penicaud, L1
Casteilla, L1
Rigoulet, M1

Other Studies

1 other study available for pyruvic acid and HIV-Associated Lipodystrophy Syndrome

ArticleYear
Site specific alterations of adipose tissue mitochondria in 3'-azido-3'-deoxythymidine (AZT)-treated rats: an early stage in lipodystrophy?
    Biochemical pharmacology, 2005, Jul-01, Volume: 70, Issue:1

    Topics: Adipose Tissue; Animals; Anti-HIV Agents; DNA, Mitochondrial; Electron Transport Complex IV; HIV-Ass

2005